DONYA CARTER: Open Payments
NPI 1407366735 · CONGERS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,081 in 33 payments from 11 companies in 2025. Trend: 2023 $2,606 · 2024 $1,360 · 2025 $1,081
Food & beverage: $1,081
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $220 |
| Lilly USA, LLC | 6 | $181 |
| Braeburn Inc. | 7 | $136 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $125 |
| PFIZER INC. | 6 | $122 |
| Novo Nordisk Inc | 1 | $118 |
| AstraZeneca Pharmaceuticals LP | 1 | $65 |
| Exact Sciences Corporation | 2 | $35 |
| Indivior Inc. | 2 | $33 |
| ViiV Healthcare Company | 1 | $27 |
Products named: VRAYLAR, BRIXADI, ZEPBOUND, Wegovy, FASENRA, PAXLOVID, MOUNJARO, ELIQUIS.
Industry payments across NY — which companies pay providers there.
